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Abstract
Background: The aim of this study was to develop and evaluate a brief quantitative five-language measure of
involvement and satisfaction in clinical decision-making (CDIS) – with versions for patients (CDIS-P) and staff
(CDIS-S) – for use in mental health services.
Methods: An English CDIS was developed by reviewing existing measures, focus groups, semistructured
interviews and piloting. Translations into Danish, German, Hungarian and Italian followed the International
Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force principles of good practice for
translation and cultural adaptation. Psychometricevaluation involved testing the measure in secondary mental
health services in Aalborg, Debrecen, London, Naples, Ulm and Zurich.
Results: After appraising 14 measures, the Control Preference Scale and Satisfaction With Decision-making
English-language scales were modified and evaluated in interviews (n = 9), focus groups (n = 22) and piloting
(n = 16). Translations were validated through focus groups (n = 38) and piloting (n = 61). A total of 443 service
users and 403 paired staff completed CDIS. The Satisfaction sub-scale had internal consistency of 0.89 (0.86-0.89
after item-level deletion) for staff and 0.90 (0.87-0.90) for service users, both continuous and categorical (utility)
versions were associated with symptomatology and both staff-rated and service userrated therapeutic alliance
(showing convergent validity), and not with social disability (showing divergent validity), and satisfaction
predicted staff-rated (OR 2.43, 95%CI 1.54- 3.83 continuous, OR 5.77, 95%CI 1.90-17.53 utility) and service
user-rated (OR 2.21, 95%CI 1.51-3.23 continuous, OR 3.13, 95%CI 1.10-8.94 utility) decision implementation
two months later. The Involvement sub-scale had appropriate distribution and no floor or ceiling effects, was
associated with stage of recovery, functioning and quality of life (staff only) (showing convergent validity), and
not with symptomatology or social disability (showing divergent validity), and staff-rated passive involvement by
the service user predicted implementation (OR 3.55, 95%CI 1.53-8.24). Relationships remained after adjusting for
clustering by staff.
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Conclusions: CDIS demonstrates adequate internal consistency, no evidence of item redundancy, appropriate
distribution, and face, content, convergent, divergent and predictive validity. It can be recommended for research and
clinical use. CDIS-P and CDIS-S in all 3 five languages can be downloaded at www.cedar-net.eu/instruments.
Trial registration: ISRCTN75841675.
Keywords: Clinical decision-making, Involvement, Satisfaction, Mental health, Psychometric, Translation, Patient reported
outcome measure, Recovery
Background
All clinical care results from a series of decisions made
by staff and service users. Decision making is a complex
and dynamic social interaction [1]. The balance of in-
volvement between staff and service user can be concep-
tualised as a continuum from paternalistic or passive,
(decision is made by the staff, service user consents)
through shared (information is shared and decision jointly
made) to informed or active (staff informs, service user
decides) [2].
The optimal decision-making style varies across indi-
viduals and decision types [3]. Influences might include
level of preference for information, existence of available
treatment options, involvement in shared decision mak-
ing, and decisions which are more values-based (i.e. where
clinical equipoise exists) versus those that where there is a
clearly superior treatment option. Empirical evidence from
physical health settings suggests that shared decision mak-
ing leads to better outcomes, including help-seeking be-
haviour [4], increased compliance with decisions [5],
reduction in errors [6], reduced stigma and increased
involvement [7]. Shared decision making involves clin-
ician and patient as active agents in the decision making
process, with both bringing information and values into
the discussion, evaluating the options and taking steps to
build a consensus [8]. Although shared decision making
is recommended in clinical guidelines [9], the research
base for SDM in mental health settings is limited. A
Cochrane review of shared decision making in mental
health concluded that there was insufficient evidence to
draw firm conclusions, and highlighted an “urgent need
for further research” [10].
Despite this evidence base, paternalistic decision-
making remains common [1]. A primary flow of infor-
mation from staff to service user means that the service
user’s values and treatment preferences may be given
less importance [11]. This is particularly problematic in
a mental health context, where a positive working rela-
tionship supports recovery [12] and where many clinical
decisions relate to the broader functioning and disability
issues rather than primarily to reducing pathology. Inter-
ventions are now being developed to redress this im-
balance [13], but challenges remain. Perceptions about
level of involvement differ, with service users identifying
paternalistic and staff identifying shared approaches [14].
In common with other mental health domains such as
need and therapeutic alliance [15], this indicates the
importance of separately assessing staff and service user
perspectives [16].
Research into satisfaction in mental health care usually
looks at the overall experience, using measures of satis-
faction with overall care [17,18] rather than with a specific
decision. Despite the increasing availability of decision-
making measures [19], there remains a need for a short
standardised measure of involvement and satisfaction with
a specific decision, which is suitable for use across a range
of clinical settings and countries [20].
The aim of this study was to develop and evaluate a
quantitative measure of involvement and satisfaction
with a specific clinical decision, with staff-rated and ser-
vice user-rated versions each in five languages (Danish,
English, German, Hungarian and Italian). The measure
was called Clinical Decision-making Involvement and
Satisfaction (CDIS). Five principles were used to inform
the development of CDIS:
1. In line with research into other subjective constructs
[21,22], there are likely to be differing perspectives
between staff and service users, so separate
assessments for use by staff (CDIS-S) and service
users/patients (CDIS-P) are needed.
2. Since involvement and satisfaction can vary for
different decisions even within the same meeting,
the rating is made in relation to a single decision
3. Parochial references to a particular professional
group, or a style or setting of working, are to be
avoided to minimise country-specific items which
reduce cross-cultural validity.
4. The measure should be as brief and easy to use as
possible, to maximise its utility for both research
and routine clinical use.
5. CDIS should as far as possible be based on existing
standardised measures.
Methods
Design
The study comprised three stages. Stage 1 (Development
of source language CDIS) involved literature review of
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existing standardised measures, focus groups, semi-
structured individual interviews and draft measure devel-
opment. Stage 2 (Development of target language CDIS)
was based on the International Society for Pharmacoeco-
nomics and Outcomes Research (ISPOR) Task Force prin-
ciples of good practice for the translation and cultural
adaptation of patient-reported outcome measures [23].
The ISPOR Framework identifies ten sequential steps: 1
preparation; 2 forward translation; 3 reconciliation; 4 back
translation; 5 back translation review; 6 harmonisation;
7 cognitive debriefing; 8 review of cognitive debriefing re-
sults and finalisation; 9 proof-reading; and 10 final report.
We refer to these steps as ISPOR 1 to ISPOR 10 re-
spectively. Finally, Stage 3 (Psychometric evaluation) in-
vestigated stability and validity across all six sites.
Setting
Sites in six European countries participated: Ulm Uni-
versity, Germany (coordinating centre for the study);
Institute of Psychiatry, King’s College London, England
(lead for this sub-study); University of Naples SUN, Italy;
Aalborg Psychiatric Hospital, Denmark; Debrecen Uni-
versity, Hungary; and University of Zurich, Switzerland.
Fuller details on each site and the overall study in which
this study was nested are published elsewhere [2]. The
study protocol was approved by ethical committees in all
six sites: Ulm University Ethics Commission; Joint South
London and Maudsley and Institute of Psychiatry Re-
search Ethics Committee; Ethical Committee of the
Second University of Naples, Naples; National Committee
on Health Research Ethics, North Denmark Region;
Regional and Institutional Ethics Committee, University of
Debrecen Medical and Health Science Center; Kantonale
Ethikkommission Zürich. Informed consent was obtained
from all service user participants.
Sample
Service user participants for Stages 1 and 2 were con-
venience samples of native speaker adults aged 18–60
using local community-based non-forensic secondary
mental health services. Staff participants worked in these
services. For Stage 3, inclusion criteria for service user
participants in the cohort study were: aged 18–60; suffi-
cient command of the local language; having a primary
research diagnosis of mental disorder other than learn-
ing disability, dementia, substance abuse or organic brain
disorder established using Structured Clinical Interview
for DSM-IV (SCID) [24]; cognitive ability to give in-
formed consent and complete study measures; expected
contact with services during the study period; and presence
of a severe mental illness for at least two years. Severity
was tested using the Threshold Assessment Grid (TAG)
[25], a measure of mental health problem severity with
adequate psychometrics [26] and feasibility [27], and for
which a score of 5 or more (range 0 to 24) was used as an
inclusion criterion as it indicates mental illness severity suf-
ficient to warrant specialist mental health care [28]. A
paired member of staff was identified by the service user.
Measures
The topic guides for Stage 1 individual interviews in
England and focus groups in Germany were developed
by the local researchers, and explored the conceptual
understanding of clinical decision-making. Topics cov-
ered included experience of making decisions, and level
of involvement and satisfaction with the process. The
topic guides for Stage 2 focus groups incorporated the
conceptual questions developed during Stage 1, along
with discussion of the draft CDIS in relation to compre-
hensibility, aspects to improve and feasibility.
The Feasibility Questionnaire is a 6-item respondent-
rated study-specific measure assessing feasibility [29],
covering length, conceptual comprehensibility, language
comprehensibility, acceptability, and conceptual coverage
of involvement and satisfaction. This approach has been
used to investigate the feasibility of other measures [30,31].
Each item is rated from 0 (worst) to 4, and feasibility is ad-
equate if the mean rating is more than 2 for each item.
Three staff-rated assessments were used to assess val-
idity in Stage 3 (Psychometric evaluation). The Global
Assessment of Functioning (GAF) is a one-item global
measure of symptomatology and social functioning, with
a scale ranging from 1 (worst) to 99 (best) [32]. The
Health of the Nation Outcome Scales (HoNOS) is a
12-item assessment of social disability, with a summary
score ranging from 0 (worst) to 48 (best) [33]. The
Helping Alliance Scale – Staff (HAS-S) is a five-item
measure of therapeutic alliance, with a summary score
ranging from 0 (worst) to 10 (best) [34]. Specific HAS-S
items used in this study were item 4 (“Do you feel you
are actively involved in the treatment of the service
user?”) and item 5 (“Do you feel you can help and effect-
ively treat the service user?”).
Four service user-rated assessments were used to as-
sess validity in Stage 3 (Psychometric evaluation). The
Outcome Questionnaire-45 (OQ-45) is a 45-item measure
of symptomatology, with a total score (TOT) ranging from
0 (best) to 180 (worst) [35]. The HAS – Patient (HAS-P)
is a six-item measure of therapeutic alliance, with a sum-
mary score ranging from 0 (worst) to 4 (best) [34]. Specific
HAS-P items used in this study were item 4 (“Is your staff
member committed to and actively involved in your treat-
ment?”) and item 6 (“How do you feel immediately after a
session with your staff member?”). The Manchester Short
Assessment (MANSA) is a 12-item measure of quality of
life, with a summary score ranging from 1 (worst) to 7
[36]. The 30-item version of the Stages of Recovery Inven-
tory (STORI) allocates participants to one of five stages of
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recovery. Because the original psychometric study [37] and
two replication studies [38,39] all identified a 3-cluster
solution better fitted the data, the summary score was allo-
cation to one of three stages: Moratorium, Awakening/
Preparation, Rebuilding/Growth.
Procedures
Stage 1 (Development of source language CDIS)
Three sources of data were used to develop the draft
CDIS in English from February 2009 to May 2009. First,
a non-systematic scoping review [40] was undertaken to
identify existing standardised self-rated English-language
measures of involvement and satisfaction in clinical
decision-making from both service-user and staff per-
spectives. The Web of Knowledge database was searched
using the terms: measures, decision making, satisfaction,
mental illness, shared decision making, mental health care,
and decision making involvement. Key psychometric prop-
erties were rated independently by two raters using cat-
egories shown in Table 1, with disagreements resolved
through team discussion. Permission was sought from the
authors of measures which were to be modified for use in
CDIS. Consideration was given to inviting the instrument
developer to be involved in the translation process, but no
measure was identified which overlapped sufficiently with
the intended focus and use of CDIS, so no instrument de-
veloper was involved beyond giving permission.
Second, individual interviews about the concept of
clinical decision-making were undertaken in England
with a convenience sample of staff and service users.
The topic guide asked about types of decision, level of in-
volvement and satisfaction experienced, and approaches
to decision-making. Service user participants were paid
£5 for their involvement.
Third, focus groups about the concept of clinical
decision making were undertaken in Germany with a
convenience sample of service users [49]. Data were col-
lected in Germany to provide a comparison with the data
from England, so as to identify culturally-specific aspects
which were less applicable for use in the measure. Partici-
pants were paid €10 for their involvement.
On the basis of these three sources of data, a draft
English CDIS was developed in English (the ‘source’
language) with two versions: service user-rated CDIS-P
and staff-rated CDIS-S. This was then evaluated in England
with a further focus groups with service users and staff
(topic guide: decision-making, comments on draft CDIS),
modified and then piloted with both staff and service
users (completing CDIS and Feasibility Questionnaire).
The draft CDIS was modified to produce the final English
CDIS.
Stage 2 (Development of target language CDIS)
ISPOR Stages 1 to 3: forward translation and recon-
ciliation All ten stages of the ISPOR principles were
used. Preparation (ISPOR stage 1) was undertaken at a
study meeting involving researchers from all six study sites
held in Ulm in May 2009. A forward translation (ISPOR
stage 2) of CDIS into the four ‘target’ languages (Danish,
German, Hungarian and Italian) was made by bilingual
translators in each country who were native speakers in
the target language. Consideration was given to producing
multiple forward translations to minimise the impact of an
individual’s writing style on the translation, but this proved
unnecessary as the translation task was relatively straight-
forward and the ISPOR guidelines indicated low agreement
on how multiple forward translations are reconciled into
one final version. In order to maximise the conceptual
equivalence of the draft CDIS, a staff focus group and a
service user focus group were held in all six countries. Rec-
onciliation (ISPOR stage 3) comprised careful review of the
forward translation and the results from the focus groups
Table 1 Summary of psychometric properties of measures (n = 8)
Measure Content
validity
Construct
validity
Floor/Ceiling
effect
Internal
consistency
Reliability Brevity Simplicity Relevance
Measures of involvement only
Patients Preference for Control [41] Unknown Unknown Unknown Unknown Unknown Adequate Adequate Adequate
Control Preferences Scale [42] Unknown Adequate Unknown Unknown Adequate Adequate Adequate Adequate
Facilitation of Patient Involvement [43] Unknown Adequate Unknown Adequate Adequate Adequate Adequate Doubtful
Desire to Participate in Medical Decision
Making Scale [44]
Adequate Doubtful Unknown Adequate Adequate Adequate Adequate Doubtful
Decision Self-Efficacy Scale [45] Unknown Adequate Unknown Adequate Adequate Adequate Adequate Poor
Measures of satisfaction only
Satisfaction with Decision Scale [46] Unknown Adequate Unknown Adequate Adequate Adequate Adequate Adequate
Measures of involvement and satisfaction
Decisional Conflict Scale [47] Unknown Adequate Unknown Adequate Adequate Adequate Adequate Poor
Autonomy Preference Index [48] Adequate Adequate Poor Adequate Adequate Poor Doubtful Doubtful
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by each site to ensure conceptual equivalence with the
aims of the measure discussed at the Ulm meeting.
ISPOR stages 4 to 5: back translation
A back translation (ISPOR stage 4) of each translated
version was then made by a different bilingual translator
into English, without knowledge of the original English ver-
sion. Back-translation is a quality control step to demon-
strate that the target language version does not have a
different content or conceptual basis which would com-
promise psychometric properties and reduce data quality.
As the constructs being assessed were subjective, a focus
on conceptual rather than literal translation was used.
The back translation review (ISPOR stage 5) was under-
taken by researchers at the English site. Reconciliation to
ensure the conceptual equivalence of the translation in-
volved identification of discrepancies between the original
English language version and the back translation, and re-
finement of the target language versions. The aim was to
minimise mistranslation or omission.
ISPOR stages 6 to 10: harmonisation and review
Following harmonisation (ISPOR stage 6) of all target
language translations on the basis of back translations,
the source and all four target language versions of
CDIS were piloted using cognitive debriefing (ISPOR
stage 7) in each country. The aim was to assess the
level of comprehensibility and cognitive equivalence of
the translations, and to highlight items that may be in-
appropriate at a conceptual level. The ISPOR guidance
indicates that testing should involve five to eight re-
spondents who are native speakers of the target lan-
guage and represent the target population in clinical
and sociodemographic characteristics. Therefore piloting
was undertaken with community-based non-forensic sec-
ondary adult mental service users and associated staff in
each country (including England). Participants were paid
£10 or the local equivalent for their involvement in some
sites.
Finally, a review of the cognitive debriefing and final-
isation of all new translations (ISPOR stage 8) was com-
pleted at a study meeting involving researchers from all
six study sites, held in Zurich in September 2009. Fol-
lowing careful proof-reading (ISPOR stage 9) by all sites,
this produced agreement on the final CDIS with staff
and service user versions in five languages. This paper
comprises the final report (ISPOR stage 10) of the process,
along with the final report to be submitted to the study
funders when the study has concluded.
Stage 3 (Psychometric evaluation)
Psychometric properties were investigated using data
collected in a six-country cohort study. A cohort of service
users with TAG score of 5 or more (indicating more severe
mental illness) was identified and recruited between
November 2009 and November 2010 in each site.
Service users identified a member of staff whom they saw
regularly, and then identified a specific decision made at
their last meeting (generally within the last two weeks). A
decision was defined as a topic which was (a) discussed,
with the result that (b) either changes were made or there
was agreement that no changes should be made. The ser-
vice user then completed CDIS-P in relation to that deci-
sion, HAS-P in relation to the nominated staff member,
OQ-45, MANSA and STORI. Their nominated staff mem-
ber was informed of the decision and asked to complete
CDIS-S, HAS-S, HoNOS and GAF. Research diagnosis
was established by the researchers using SCID from clinical
notes. Service users were paid £20 (or local equivalent) and
staff were paid £10 for their involvement (which included
completion of other measures not reported here) in some
sites. Two months later, service users and staff were asked
whether they had implemented the decision (Yes, Partly
or No). Service users were paid £5 for their involvement
in some sites.
Data from all sites were electronically collated into
a central database, with data cleaning led by the co-
ordinating centre. Cleaning involved data validation
and data verification. Data validation involved (i) checking
the case-level data were internally consistent, and (ii) iden-
tifying outlier ratings, asking the originating site to manu-
ally check each identified outlier rating against paper
and local electronic databases, and correcting the cen-
tral database where necessary. Data verification involved
identifying remaining outliers and deciding whether to
include them in the analysis on the basis of plausibility,
i.e. whether they were reasonable ratings and whether
they correlated with other contemporaneous ratings for
the same participant.
Analysis
All focus groups and interviews were recorded and tran-
scribed into the local language. For the focus groups,
consideration was given to translating transcripts into
English and then back-translating to validate the transcript
prior to analysis of the aggregated English transcripts. This
approach was not used because the qualitative aspect of
the study was not focussed on developing an overall
conceptual understanding of clinical decision-making
across all sites. Rather, the aim of all focus groups was
more local - either to provide data relating specifically
to the local language version of CDIS or to provide a
thematic overview of the conceptual meaning of clinical
decision-making in each site, so as to ensure broad
conceptual equivalence. Therefore thematic analysis of
both interviews and focus groups was undertaken lo-
cally, without translation into English. This involved the
development by two independent analysts of an initial
Slade et al. BMC Health Services Research 2014, 14:323 Page 5 of 15
http://www.biomedcentral.com/1472-6963/14/323
coding framework capturing the overarching and re-
lated sub-themes within the local language transcript,
which was then synthesised through discussion with
modification or addition of codes until theoretical sat-
uration was obtained. An English version of the coding
framework was generated by local translation of the
coding framework into English, which was then reviewed
by a native English speaker and modified by the local site if
necessary.
The investigation of internal consistency used Cronbach’s
alpha, with a score between 0.70 and 0.95 indicating good
internal consistency [50]. A higher alpha was acceptable
because for shorter scales (such as CDIS) all items may be
clinically informative rather than indicating item redun-
dancy. Item-level deletion was use to investigate whether
removal of any item would markedly improve internal
consistency. Floor and ceiling effects are particularly im-
portant with CDIS since the aim is to compare between
groups, and such effects may make it impossible to deter-
mine the central tendency and hence detect difference.
Therefore the distribution across the range of scores was
investigated, with normal distribution indicating minimal
floor or ceiling effects. Construct validity was investigated
in two ways. First, convergent validity was investigated by
testing relationships assumed to co-vary. CDIS Involve-
ment was expected to relate specifically to stage of recov-
ery (STORI), and also to functioning (GAF) and subjective
well-being (MANSA). CDIS Satisfaction was expected to
relate to the relationship (HAS-S and HAS-P) and symp-
tom distress (OQ-45 symptom distress sub-scale). Second,
divergent validity was investigated by testing relationships
assumed not to correlate: CDIS and symptoms (OQ-45
symptom distress sub-scale) and social disability (HoNOS).
The ordinal STORI analysis involved cross-tabulation with
STORI category, ordinal logistic regression to estimate the
probability of participants being in a less active CDIS cat-
egory with lowest recovery stage (Moratorium) as refer-
ence category, and Wald test to test null hypothesis of no
difference in odds ratio of being in a less active CDIS
category. Other variables were continuous, so bivariate re-
lationships were assessed using Spearman's Rank correl-
ation. Following these analyses, adjustment was made for
staff rating more than one service user. For CDIS Involve-
ment and the categorical CDIS Satisfaction (utility), uni-
variable ordinal logistic regression models were used
including a random effect to adjust for clustering by staff,
with results reported as odds ratios showing the odds of
being in a higher CDIS category. For the continuous CDIS
Satisfaction, univariable linear regression models including
a random effect to adjust for clustering by staff and with
resampling using bootstrapping (5000 repetitions) was
used. Predictive validity was analysed by comparing satis-
faction and involvement with ratings by the same rater
(staff/service user) of implementation of the decision
(Yes vs. Partly vs. No) made 2 months later. Satisfaction
was expected to predict implementation, whereas involve-
ment was not (since no a priori stance was taken in this
study about the relative merits of different involvement
experiences). Ordinal regression models were estimated
with a random effect to adjust for clustering by staff.
For categorical predictors (Involvement and Satisfaction
(Utility)), odds ratios show the estimated odds of being in
a higher implementation category for this category as
compared to the reference category (Active involvement
and Low satisfaction respectively). For continuous pre-
dictors (Satisfaction), odds ratios show the estimated
odds of being in a higher implementation category for
every one unit increase in predictor. All quantitative ana-
lyses were undertaken using SPSS 19.0 and Stata 11.2.
Results
Stage 1 (Development of source language CDIS)
The literature review identified 218 papers. Titles and
abstracts were reviewed, identifying 14 measures. The
relevant articles and measures were obtained and reviewed.
Six measures were excluded as they assessed satisfaction
with more general aspects of care [51-55] or were not self-
rated [56]. The psychometric properties for the remaining
eight measures are shown in Table 1.
Two measures provided the strongest evidence of
psychometric properties. The Control Preference Scale
(CPS) is a single-item patient-rated measure of preferred
style of involvement [42]. The scale comprises Active
(“I prefer to make the final selection about which treat-
ment I will receive”, “I prefer to make the final selection
of my treatment after seriously considering my doctor’s
opinion”), to Collaborative (“I prefer that my doctor and
I share responsibility for deciding which treatment is best
for me”) and Passive (“I prefer that my doctor make the
final decision about which treatment will be used, but
seriously consider my opinion”, “I prefer to leave all deci-
sions about my treatment to my doctor”). It was initially
developed for use in cancer patients, but has been
adapted and used with mental health populations [57,58].
The Satisfaction With Decision-making (SWD) scale is a
6-item patient-rated measure of satisfaction [46]. The
items cover adequacy of supplied information, was it the
best decision, consistency with personal values, expect-
ation of full implementation, whether it was my decision,
and overall satisfaction. The five-point scale ranges from
Strongly Disagree to Strongly Agree. SWD was originally
developed in the context of postmenopausal hormone-
replacement therapy decisions [46], and has been vali-
dated for use with people with depression [59].
Interviews about clinical decision-making were held
with four service users (age 33–46, 3 female, all psych-
osis diagnosis) and five staff (nurse, clinical psychologist,
psychiatrist, occupational therapist, educator). A range
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of types of decision were identified: most commonly
medication and psychological treatments, but also for
example pre-conception counselling, diet, housing, ben-
efits, structuring time, involvement of a relative, and em-
ployment. Influences on satisfaction identified by service
users were level of choice, preferences being respected,
setting the agenda for the conversation, saying what I
want to say, and the relationship with staff. For staff,
influences on their satisfaction were the relationship,
being empowering, role conflict (therapeutic benefit
versus risk management), giving information, level of
collaboration, and supporting the service user to de-
cide. Both service users and staff highlighted the ethical
and power balances involved in decision-making con-
versations, with one stating “it’s more about a learning
process, not all-or-none”. There was consensus that the
best outcome occurs when service user makes a deci-
sion with which both agree. These interviews informed
the measure by: (i) identifying the need for the wording
to be generic, rather than assuming that the decision is
about treatment; (ii) identifying the influences on in-
volvement and satisfaction differ, pointing to the need for
separate staff and service user versions; and (iii) identify-
ing that comparable versions to allow direct comparison
were preferable to incompatible staff and service user
versions.
Two focus groups were conducted in Germany with
service users only (n = 3 and n = 5). The emergent cod-
ing framework (not reported in full) identified themes of
the nature of the illness (burden, course), relationships
(how staff perceive the service user, staff response to
non-cooperation, how mis-communication is handled),
service user characteristics (communication difficulties,
how illness is understood), the nature of the decision
(type, who is involved, whether implemented and why)
and decision-making processes (information supplied,
involvement) [49]. These findings were consistent with the
London interviews.
Overall the qualitative data indicated conceptual equiva-
lence could be achieved by modifying CPS (to meas-
ure involvement in a specific decision rather than
general preference) and SWD (to modify administration
instructions). A draft English CDIS was developed using
these measures, with modifications in items to produce a
staff-rated version. Other modifications were formatting
and instructions for raters. The draft English CDIS was
then evaluated in two ways. A service user focus group
(n = 7, 3 female) identified that the six-item satisfaction
scale looked “all the same”, commented on wording and
how to identify who made the decision, and preferred the
1-item Involvement Sub-scale as clearer. The staff focus
group (n = 7, 5 female, nurse/occupational therapist/
social worker/support worker) contrasted team and
individual staff views, wanted to record dissent when the
service user makes a non-consensus decision, challenged
the assumption that there is one ‘best’ decision, identified
that the optimal amount of involvement in decision-
making differs, and noted the absence of carer involve-
ment. As a result, the draft English CDIS wording was
modified (“I” became “We” in CDIS-S), administration
instructions were made more accessible and modified to
suggest the first administration is done with service user
(to ensure comprehension), the Involvement sub-scale
was finalised as categorical (to indicate that different
points may be desirable in different situations), and a
comments box was added to the staff version. Piloting of
CDIS with service users (n = 9) and staff (n = 7) evaluated
feasibility, finding adequate results with mean ratings on
the Feasibility Questionnaire ranging for service users
from 2.89 to 3.22, and for staff from 2.75 to 3.25.
The final version of the Clinical Decision-making In-
volvement and Satisfaction (CDIS) scale is shown in
Table 2.
CDIS is rated in relation to a specific identified deci-
sion. The Involvement sub-scale comprises one item
about level of involvement experienced, which uses five
categories. Categories 1 and 2 are collapsed (as their dis-
tinction may reflect social desirability bias rather than
different experiences) to be scored as Active involve-
ment, category 3 is Shared involvement, and categories 4
and 5 are collapsed to Passive involvement. Note there-
fore that staff-rated Passive involvement indicates pas-
sive involvement by the service user, i.e. active staff
involvement. The Satisfaction sub-scale is valid if all six
items are rated, and is scored as the mean of all items,
ranging from 1 (low satisfaction) to 5.
Stage 2 (Development of target language CDIS)
The draft CDIS was translated into each target language
(Danish, German, Hungarian, Italian). Focus groups were
then held in Naples (n = 4 service users, n = 5 staff ),
Aalborg (n = 3 service users, n = 4 staff), Debrecen (n = 4
service users, n = 5 staff) and Zurich (n = 6 service users,
n = 7 staff). The relevant target language CDIS was modi-
fied in the light of the focus group, to maximise concep-
tual equivalence without compromising psychometrics.
For example, the Danish translation of item 3 deleted
“I am satisfied that” to increase comprehensibility of
the item in Danish. A back translation into English was
made, and reviewed in the London site, with a focus on
conceptual equivalence and modifications to the target
language CDIS made as indicated. The CDIS was then
completed by a sample of service users (n = 30) and
staff (n = 31) across all languages. For both groups, rat-
ings for all Satisfaction items spanned at least four of
the five possible ratings, and ratings for the Involve-
ment item spanned at least four of the five categories,
giving preliminary evidence of useability and no indication
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of floor or ceiling effects. Cognitive debriefing following
administration identified no further modifications for any
target language. The final CDIS-S and CDIS-P for each
country were finalised in a study meeting. The develop-
ment process involving the key stake-holders of staff and
service users ensured adequate face validity and content
validity.
Stage 3 (Psychometric evaluation)
A total of 443 service users provided CDIS data. Service
user characteristics and outcome assessments are shown
in Table 3.
152 staff provided complete CDIS data for 405 (91%) of
these 443 service users (pooled sample 45% male, mean
age 44.0 years, 54% psychiatrist/36% care co-ordinator/
7% psychologist/3% social worker, mean 15.3 years work
experience).
Stability
The distribution of CDIS scores across sites is shown in
Table 4.
For staff, CDIS Satisfaction sub-scale (rated for 403
service users) internal consistency was 0.89, internal
consistency after item-level deletion ranged from 0.86 to
0.89, and distribution of scores across the range was 1%
1.0-2.0, 3% 2.1-3.0, 48% 3.1-4.0 and 43% 4.1-5.0. CDIS
Involvement sub-scale (rated for 404 service users) dis-
tribution comprised Passive involvement n = 94 (23.3%),
Shared involvement n = 187 (46.3%) and Active involve-
ment n = 123 (30.4%).
For service users, CDIS Satisfaction sub-scale internal
consistency was 0.90, internal consistency after item-
level deletion ranged from 0.87 to 0.90, and distribution
of scores across the range was 1% 1.0-2.0, 5% 2.1-3.0,
42% 3.1-4.0 and 52% 4.1-5.0. CDIS Involvement (rated
by 443 service users) comprised Passive involvement
n = 118 (26.6%), Shared involvement n = 219 (49.4%) and
Active involvement n = 106 (23.9%).
In summary, for the Involvement sub-scale, there was
appropriate distribution variation across sites as would
be anticipated from cultural differences, with no indica-
tion of floor or ceiling effects.
For the Satisfaction sub-scale there was good evidence
for internal consistency, with no indication of item re-
dundancy. Distribution was right-skewed as is typical
with satisfaction data. The validity of analysing CDIS
Satisfaction as a collapsed ordinal scale was therefore in-
vestigated. Categories were formulated on the basis of
utility where an emphasis was placed on separating cat-
egories according to clinical meaningfulness. Participants
with extremely low satisfaction (rating satisfaction items
as ‘Strongly disagree’) transitioning to low satisfaction
(mostly rating items as ‘Disagree’) or towards moderate
(mostly rating ‘Neither disagree nor agree’) would indi-
cate a marginal improvement but remain an unsatis-
factory endpoint. The ‘moderate satisfaction’ category
comprised participants rating the majority of satisfaction
items as ‘Agree’ with some items neutral, and high satis-
faction captured participants recording almost or every
satisfaction item as ‘Strongly agree’. These categories of
Table 2 Contents of final CDIS
Wording in CDIS-S Wording in CDIS-P
Involvement sub-scale (one item) Score
The service user made the final decision I made the final decision. Active
The service user made the final decision after
seriously considering my opinion
I made the final decision after seriously considering
my clinicians opinion
Active
The service user and I shared responsibility for
making the best decision for them
My clinician and I shared responsibility for making
the best decision for me
Shared
I made the final decision, after seriously considered
the service user’s opinion
My clinician made the final decision, but seriously
considered my opinion
Passive
I made the final decision My clinician made the final decision Passive
Satisfaction sub-scale (six items) Rating scale
1. I had adequate information from the service user
about the issues important to them
1. I am satisfied that I am adequately informed
about the issues important to the decision
5-point Likert scale from 1
(Strongly disagree) to 5
(Strongly agree)
2. The decision we made was the best decision
possible in my view
2. The decision we made was the best decision
possible in my view
3. I am satisfied that the decision was consistent
with my personal and professional values
3. I am satisfied that the decision was consistent
with my personal values
4. I expect the decision we made to be successfully
acted on/continued to be acted on
4. I expect the decision we made to be successfully
acted on/continued to be acted on
5. I am satisfied that this was the decision to make 5. I am satisfied that this was the decision to make
6. I am satisfied with the decision 6. I am satisfied with the decision
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low (1.0-3.0), moderate (3.01-4.0) and high (4.01-5.0) sat-
isfaction were assigned uniformly distanced (ordinal) util-
ities of 0, 1 and 2 respectively. The categories therefore
distinguish groups by their ordinal nature but not by
a specific value assigned to each category. Transitions
from low to moderate satisfaction and from low to high
satisfaction are of primary clinical interest. The transition
from moderate to high satisfaction is useful as a clinical
target which makes use of the positive skew that is char-
acteristic of satisfaction data. Distribution was more
balanced than for the continuous rating: staff 17 (4.2%)
low, 204 (50.5%) moderate, 183 (45.3%) high, and service
Table 3 Sociodemographic and clinical characteristics of service users (n = 443)
Ulm London Naples Aalborg Debrecen Zurich Total
n 91 43 86 70 95 58 443
Male (%) 29 (32) 32 (74.4) 46 (53.5) 31 (44.3) 49 (51.6) 18 (31) 205 (53.7)
Age in years (s.d.) 45.6 (9.1) 45.2 (10.6) 43 (10.5) 39.8 (10.7) 45.2 (10) 40.4 (10.6) 42.5 (10.4)
Years in education (s.d.) 10.6 (1.7) 11.2 (1.9) 11.2 (1.9) 9.7 (1.1) 11.3 (1.3) 9.7 (1.4) 10.5 (1.9)
Marital status (%)
Unmarried 32 (35) 37 (86) 39 (45) 41 (59) 43 (45) 28 (48) 220 (50)
Married/co-habiting 29 (32) 2 (4.2) 32 (37) 12 (17) 32 (34) 15 (26) 122 (28)
Separated/divorced/widowed 30 (33) 4 (9.4) 15 (17) 16 (23) 20 (21) 15 (26) 100 (23)
Living situation (%)
Alone 50 (55) 13 (30.2) 13 (15) 40 (57) 21 (22) 36 (63) 173 (39)
With spouse/partner 31 (34) 2 (4.7) 35 (40) 18 (26) 34 (36) 16 (28) 136 (31)
With others 10 (11) 28 (65.1) 37 (43) 12 (17) 40 (42) 5 (9) 132 (30)
Employment (%)
Paid/student 24 (26) 4 (9.3) 27 (31) 4 (6) 18 (19) 21 (36) 100 (23)
Sheltered employment 5 (6) 0 1 (1) 1 (1) 3 (3) 1 (2) 11 (2)
None 60 (67) 37 (86) 56 (65) 65 (92) 73 (76) 36 (63) 327 (74)
Main income (%)
Salary 20 (22) 0 27 (31) 3 (4) 18 (19) 13 (23) 81 (19)
Benefits 20 (22) 34 (79.1) 27 (31) 20 (29) 7 (7) 3 (5) 103 (24)
Pension 40 (44) 0 2 (2) 45 (64) 67 (71) 35 (63) 189 (44)
Family support 11 (12) 2 (4.7) 38 (44) 0 1 (1) 5 (9) 57 (13)
Years since first contact with mental health services (s.d.) 14.1 (9.1) 13.1 (9.1) 12.7 (10.04) 12 (8) 13.6 (7.5) 8.7 (8.3) 12.5 (8.9)
DSM-IVR Research diagnosis
Schizophrenia and other psychotic disorders 32 (35) 25 (58.2) 23 (27) 45 (64) 54 (56) 15 (26) 194 (44)
Mood disorders 41 (45) 5 (11.6) 33 (38) 17 (24) 20 (21) 27 (47) 143 (32)
Other 18 (20) 7 (16.3) 30 (35) 8 (11) 21(22) 16 (28) 98 (22)
Mental health in-patient admissions in previous year (%) 44 (48) 11 (25.6) 0 15 (21) 23 (24) 25 (43) 118 (27)
Service user-rated outcomes
STORI (%)
Moratorium 16 (18) 7 (16) 20 (23) 13 (19) 16 (17) 13 (22) 85 (19)
Awakening/Preparation 16 (18) 13 (30) 35 (21) 7 (10) 11 (12) 15 (26) 97 (22)
Rebuilding/Growth 58 (64) 23 (54) 31 (36) 50 (71) 68 (72) 30 (52) 260 (59)
MANSA (mean, s.d.) 4.4 (1.0) 4.2 (0.8) 3.43 (0.8) 4.6 (1) 4.5 (0.8) 3.6 (1.2) 4.1 (1.0)
OQ-45 (mean, s.d.) 77.4 (28.2) 66.1 (2.6) 77.2 (22.7) 69.7 (24.7) 61.4 (23) 81.2 (26.7) 72.2 (25.9)
HAS-P (mean, s.d.) 7.1 (1.3) 6.8 (2.4) 7.3 (1) 7.2 (1.3) 7.7 (0.7) 8.1 (1.3) 7.2 (1.3)
Staff-rated outcomes
TAG (mean, s.d.) 8.2 (2.3) 8.9 (2.2) 7.6 (2.4) 7.4 (2.2) 6.3 (1.6) 6.7 (1.8) 7.4 (2.2)
HAS-S (mean, s.d.) 7.6 (1.0) 8.1 (1.0) 8.1 (1.7) 8.1 (1.2) 7.9 (1.1) 8.2 (0.8) 8.0 (102)
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users 27 (6.1%) low, 184 (41.5%) moderate, 232 (52.4%)
high. CDIS Satisfaction was subsequently analysed both as
continuous CDIS Satisfaction and categorical CDIS Satis-
faction (Utility).
Construct validity
CDIS Involvement (n = 403) was investigated using STORI
stage. Cross-tabulation indicated staff rated more active in-
volvement for Rebuilding and Growth (highest stage)
service users (82 (34%) Active, 119 (50%) Shared, 39
(16%) Passive) than Awareness and Preparation (middle
stage) (22 (26%) vs. 33 (38%) vs. 31 (36%)) and Morator-
ium (lowest stage) (18 (23%) vs. 35 (45%) vs. 24 (31%)).
Ordinal logistic regression indicated no difference in in-
volvement category between middle and lowest stage of
recovery (OR 1.1, 95%CI 0.60 to 1.96, p = 0.78) and a sig-
nificant difference between highest and lowest stage of
recovery (OR 0.52, 95%CI 0.32 to 0.84, p < 0.05). The
odds of being in a higher involvement category was
found to be significantly different between the middle
and highest stages of recovery as tested by a Wald test
on the two parameters from the model (Chi2 = 9.39,
p = 0.002). Staff rate higher CDIS Involvement for more
recovered service users.
For service users, cross-tabulation indicated more active
involvement for highest stage service users (69 (27%) vs.
129 (50%) vs. 62 (24%)) than middle stage (22 (23%) vs. 43
(44%) vs. 32 (33%)) and lowest stage (15 (18%) vs. 46
(54%) vs. 24 (28%)). Despite this trend towards a larger
proportion of more recovered service users being actively
involved (27% vs. 18%), this difference was not significant
between middle and lowest stage (OR = 1.0, 95%CI 0.58
to 1.74, p = 0.97) or between highest and lowest stage
(OR = 0.71, 95%CI 0.45 to 1.12, p = 0.14). The odds of
being in a higher involvement category was not found to
differ significantly between the middle and highest stages
of recovery as tested by a Wald test on the two parameters
from the model (Chi2 = 2.43, p = 0.12). Service user rating
of involvement was not significantly higher for more re-
covered service users.
Convergent and divergent validity were investigated.
Unadjusted correlations are shown in Table 5. (Lower
Involvement score means more active involvement of the
service user).
For staff ratings, convergent and divergent validity
were demonstrated: staff identified more involvement
from service users in later stages of recovery and with
higher functioning and better quality of life, no associ-
ation between involvement and either symptomatology
or social disability, and more satisfaction when staff-
rated and service user-rated therapeutic alliance were
better and symptom distress was low. For service users,
the picture was more mixed. There was no associ-
ation between involvement and any other variable,
and satisfaction was associated with both perspectives on
therapeutic alliance. Overall, convergent validity was dem-
onstrated for both versions of the Satisfaction sub-scale
and the staff-rated Involvement sub-scale, and divergent
validity was demonstrated for both sub-scales and both
perspectives.
Some staff rated the same service user. The results of
investigating convergent and divergent validity with ad-
justment for staff clustering is shown in Table 6.
To aid interpretation of Table 6, staff ratings mean
that for every one unit increase in GAF, the odds of be-
ing in a higher CDIS Involvement category decreases by
2%. No evidence was found of association between CDIS
Involvement and MANSA, OQ-45 Symptom distress or
HoNOS. For every one unit increase in HAS-S, HAS-P
and OQ-45 symptom distress, CDIS Satisfaction in-
creases by 0.18, 0.08 and −0.006 units respectively. No
evidence was found for an association between CDIS
Table 4 CDIS Service user (n = 443) and staff (n = 405) ratings by site
Ulm London Naples Aalborg Debrecen Zurich Total
CDIS SERVICE USER n 91 43 86 70 95 58 443
Satisfaction mean (s.d.) 4.11 (0.70) 4.21 (0.92) 4.25 (0.71) 4.45 (0.53) 4.45 (0.56) 3.75 (0.58) 4.23 (0.69)
Involvement n (%)
Passive involvement 28 (31) 8 (19) 25 (29) 16 (23) 27 (28) 14 (24) 118 (26.6)
Shared involvement 36 (40) 13 (30) 50 (58) 33 (47) 57 (60) 30 (52) 219 (49.4)
Active involvement 27 (30) 22 (51) 11 (13) 21 (30) 11 (12) 14 (24) 106 (23.9)
CDIS STAFF n 80 23 86 67 95 54 405
Satisfaction mean (s.d.) 3.94 (0.53) 4.24 (0.54) 4.32 (0.58) 4.09 (0.65) 4.22 (0.61) 4.02 (0.42) 4.14 (0.58)
Involvement n (%)
Passive involvement 13 (16) 1 (4) 55 (64) 8 (12) 9 (9) 8 (15) 94 (23.3)
Shared involvement 32 (40) 9 (39) 27 (31) 23 (34) 64 (67) 32 (59) 187 (46.3)
Active involvement 34 (43) 13 (57) 4 (5) 36 (54) 22 (23) 14 (26) 123 (30.4)
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Satisfaction and HoNOS. For CDIS Satisfaction (Utility),
for every one unit increase in HAS-S, it is almost twice
as likely to be in a higher CDIS Satisfaction utility group.
For every one unit increase in HAS-P and OQ-45 Symp-
tom distress, the odds of being in a higher CDIS Satisfac-
tion utility group increase by 43% and decrease by 2%
respectively. No evidence was found for an association
between CDIS Satisfaction (Utility) and HoNOS.
Overall, these findings reflect those in the unadjusted
analysis shown in Table 5, and indicate construct validity.
Predictive validity
Predictive validity was investigated in order to show
criterion-related validity. Table 7 models the relationship
between involvement and satisfaction with the rating of
implementation by the same rater made two months later.
High satisfaction predicts implementation, for both
continuous and utility versions of the scale, and for both
staff and service users. Active involvement is associated
with lower implementation from the staff but not the
service user perspective.
Table 5 Convergent and divergent validity of CDIS sub-scales (unadjusted non-parametric correlations)
Convergent validity Divergent validity
GAF MANSA HAS-S HAS-P OQ-45 symptom distress OQ-45 symptom distress HoNOS
Staff
CDIS Involvement −0.20 −0.19 0.08 0.001
p < 0.001 p < 0.001 p = 0.10 p = 0.98
CDIS Satisfaction 0.46 0.33 −0.15 −0.08
p < 0.001 p < 0.001 p = 0.002 p = 0.13
CDIS Satisfaction (Utility) 0.38 0.30 −0.13 −0.11
p < 0.001 p < 0.001 p = 0.009 p = 0.03
Service user
CDIS Involvement −0.05 0.02 0.05 −0.008
p = 0.32 p = 0.70 p = 0.32 p = 0.87
CDIS Satisfaction 0.22 0.42 −0.24 −0.02
p < 0.001 p < 0.001 p < 0.001 p = 0.87
CDIS Satisfaction (Utility) 0.19 0.36 −0.19 −0.02
p < 0.001 p < 0.001 p < 0.001 p = 0.72
Bold p < 0.05.
Table 6 Convergent and divergent validity of adjusted CDIS sub-scales (adjusted regression models)
Convergent validity Divergent validity
GAF MANSA HAS-S HAS-P OQ-45 symptom distress OQ-45 symptom distress HoNOS
Staff
CDIS Involvement 0.98 0.78 1.01 1.01
p = 0.048 p = 0.085 p = 0.238 p = 0.817
CDIS Satisfaction 0.18 0.08 −0.006 −0.003
p < 0.001 p < 0.001 p < 0.001 p = 0.450
CDIS Satisfaction (Utility) 1.95 1.43 0.98 0.97
p < 0.001 p < 0.001 p = 0.006 p = 0.115
Service user
CDIS Involvement 0.99 0.98 1.01 −0.008
p = 0.34 p = 0.84 p = 0.137 p = 0.87
CDIS Satisfaction 0.11 0.15 −0.008 −0.008
p = 0.001 p < 0.001 p < 0.001 p = 0.276
CDIS Satisfaction (Utility) 1.35 1.59 0.98 0.98
p = 0.004 p < 0.001 p < 0.001 p = 0.248
Bold p < 0.05.
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Discussion and conclusions
The psychometric properties of the CDIS Scale were in
general adequate. The Involvement sub-scale showed
appropriate variation in distribution across sites, no
floor or ceiling effects. For staff, convergent validity
was shown in relation to stage of recovery, function-
ing and quality of life, and divergent validity in rela-
tion to symptomatology and social disability. For service
users, convergent validity was not shown in relation
to any considered co-variate, and divergent validity
was shown in relation to symptomatology and social
disability. The Satisfaction sub-scale showed internal
consistency, no item redundancy, with an anticipated
distribution skew towards the positive end of the scale.
Convergent validity was shown in relation to staff-rated
and service user-rated therapeutic alliance, and diver-
gent validity was shown in relation to social disability.
Satisfaction predicted decision implementation two months
later, as did staff-rated passive involvement of the service
user.
Our review identified five existing measures of involve-
ment, one of satisfaction, and two of both involvement
and satisfaction. A previous wider review of shared deci-
sion making measures in 2007 identified 18 measures
[60], including both measures selected in our study. The
previous review concluded, as did ours, that psychomet-
ric evaluation is absent or poor for many measures, with
a specific concern raised about validity. The focus on
assessing convergent, divergent and predictive validity of
CDIS addresses this issue.
The Satisfaction sub-scale was modified from the Sat-
isfaction with Decision Scale [46]. The original scale was
evaluated in a sample of 252 women making decisions
about management of menopause and hormone replace-
ment therapy (HRT). The scale had internal consistency
of 0.88, principal component analysis indicated dis-
criminant validity, and evidence for predictive validity
relating to decision certainty and HRT use at 12-month
follow-up. The comparability with the evaluation of CDIS
indicates that modification has not substantially compro-
mised psychometric adequacy.
Strengths and limitations
The main strengths of this study are methodology and
sample frame. The application of an established method-
ology for developing culturally valid translations of a
patient-rated outcome measure has maximised the likeli-
hood that CDIS data collected using any of the five
languages will be both comparable and conceptually
equivalent. The size of the sample, the involvement of six
countries from across Europe, and the involvement of a
routine sample of people using specialist mental health
services in each country all increase the generalisability
of the findings.
The primary limitations relate to the non-systematic
review in Stage 1, and to the psychometric evaluation
methodology. There was a relatively lower validation for
CDIS service user rating of Involvement. Although it may
be indicating that sub-scale to be less reliable or valid, the
more positive findings from other sub-scales suggests that
service user rated involvement appears to be a process
which has other influences than either satisfaction or staff-
rated involvement. Specifically, from the service user per-
spective, experience of involvement did not co-vary with
other assessed variables, and in this study there was no
gold standard independent rating of involvement which
could be used as a comparator. The OPTION Scale is an
observer-rated measure of patient involvement in decision-
making, which has been used to investigate the extent to
which psychiatrists involve service users in out-patient
consultations [61]. A future approach for further investigat-
ing convergent validity for CDIS Involvement sub-scale
might involve comparison with OPTION rating.
Clinical and research implications
CDIS is the first short, standardised measure of involve-
ment and satisfaction with a specific decision related to
mental health care, which is suitable for use across a
range of clinical settings and available in five languages.
This measure will inform clinical practice and future
research, particularly in relation to involvement in
decision-making. Most staff would argue that increased
service user satisfaction is positive. Indeed, mental health
professionals would prefer to be evaluated in relation to
Table 7 Predictive validity of CDIS scales for service users
(n = 440) and staff (n = 402)
OR (95%CI) SE P value
SERVICE USERS
Involvement
Shared vs. Active 1.54 (0.82-2,89) 0.50 0.181
Passive vs. Active 1.92 (0.94-3.94) 0.70 0.075
Satisfaction 2.21 (1.51-3.23) 0.43 <0.001
Satisfaction (Utility)
Moderate vs. Low 1.40 (0.50-3.91) 0.73 0.518
High vs. Low 3.13 (1.10-8.94) 1.68 0.033
STAFF
Involvement
Shared vs. Active 2.43 (1.31-4.50) 0.76 0.005
Passive vs. Active 3.55 (1.53-8.24) 1.52 0.003
Satisfaction 2.43 (1.54-3.83) 0.57 <0.001
Satisfaction (Utility)
Moderate vs. Low 3.33 (1.11-9.97) 1.86 0.031
High vs. Low 5.77 (1.90-17.53) 3.27 0.002
Bold p < 0.05.
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satisfaction rather than clinical improvement [62]. We
showed that CDIS Satisfaction scale can be analysed as
either continuous or three-category data, since both
show adequate validity. Whichever approach is used, our
data are consistent with an interpretation that satisfaction
with a decision-making process is relatively aligned with
other process variables capturing aspects of the therapeutic
alliance. Predictors of therapeutic alliance include age, gen-
der, severity and kind of symptoms (positive, negative,
disorganized), interpersonal factors, diagnosis, frequency of
service contact, better awareness of treatment need, and ill-
ness insight [63-68]. It is therefore plausible that these also
influence satisfaction with decision-making.
However, there might be a more mixed view among
staff about whether increased service user involvement
is always positive. Increased involvement is a priority for
service users but not staff [69]. For example, a survey of
352 psychiatrists identified a differing emphasis on level
of involvement for different patients (involvement less
important when capacity reduced) and decision topic
(more involvement endorsed for psychosocial decisions
such as work, housing and psychotherapy, less for ad-
mission, medication, diagnostic procedures) [70]. This
variability may be positive, reflecting the mature applica-
tion of clinical judgement, or inter-professional differ-
ences, or varying levels of perceived responsibility for
care between acutely unwell and less unwell service
users. This last suggestion is consistent with our data,
showing more active staff-rated involvement from more
recovered service users, which has clinical implications
for tailoring the balance of power in decision-making on
the basis of stage of recovery. Or the variability may be
negative, reflecting cognitive errors created through
clinical training [71]. The CDIS measure is feasible for
routine clinical use, and in identifying the level of in-
volvement, provides a tool to support reflective practice
by staff. For example, the association found in this study
between staff-rated passive involvement by the service
user and subsequent decision implementation is consist-
ent with a paternalistic decision-making approach by
staff leading to compliant but disempowered behaviours
by service users, which may not optimise outcome.
In relation to research, the CDIS provides a tool for
understanding the experience of a specific decision. This
allows several types of research. First, to what extent is
the experience consistent with pre-stated preferences
[72], and does this matter? Second, how do characteris-
tics of the worker, the service user, and the decision topic
influence the decision-making experience? Third, how re-
sponsive is CDIS to capturing the impact of interventions
to promote shared decision-making, and what change in
CDIS rating constitutes clinically meaningful change?
Fourth, and perhaps most importantly, do either of involve-
ment or satisfaction predict decision implementation, and
does implementation in turn predict outcome? All of these
questions are being addressed in the CEDAR Study [2].
Shared decision-making is widely advocated in mental
health services [5], and is feasible even in in-patient
settings [7]. However, distinguishing between shared
decision-making and sophisticated techniques of per-
suasion is not straightforward, Both staff [1] and service
users [11] use approaches to influence the views of the
other. There is preliminary evidence of benefit from
shared decision-making in mental health for medication
management [73,74]. However, although truly shared
decision-making is already envisioned by some [38], the
most recent Cochrane review was unable to find sufficient
robust data to determine whether shared decision-making
for people with mental health conditions is effective [10].
It is known that relationship are important in mental
health, for example in in-patient settings [75], and more
generally they support recovery [76]. CDIS data may con-
tribute to the development of a stronger empirical under-
pinning of when, and why, high involvement of mental
health service users in decision-making is beneficial.
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